beta-blocking agents and human fat cell adenylate cyclase
- PMID: 20652
beta-blocking agents and human fat cell adenylate cyclase
Abstract
The effects of various beta-blocking agents upon the catecholamine-activated adenylate cyclase of human fat cell ghosts were studied. Both non-selective and cardio-selective beta-blocking drugs are capable in inhibiting the human enzyme system. The concentrations of the non-selective beta-blockers (bupranolol, alprenolol, propranolol, 4-hydroxypropranolol, prindolol and oxyprenolol) required to produce half maximal inhibition of isoproterenol-stimulated rates of cAMP-formation were found to be in a narrow range (5X10(-7) M-3X10(-6) M).The cardioselective beta-blocking agents, however, were only 1/100 (methypranol) to 1/1000 (atenolol, practolol) as potent as the non-selective drugs.
Similar articles
-
Effects of salbutamol and butoxamine on the human fat cell adenylate cyclase.Horm Metab Res. 1980 Dec;12(12):695-7. doi: 10.1055/s-2007-999234. Horm Metab Res. 1980. PMID: 6259042
-
The effect of alpha and beta adrenergic receptor stimulation on the adenylate cyclase activity of human adipocytes.J Cyclic Nucleotide Res. 1975;1(5):321-8. J Cyclic Nucleotide Res. 1975. PMID: 1225939
-
Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.Mol Pharmacol. 1984 Sep;26(2):206-13. Mol Pharmacol. 1984. PMID: 6207420
-
Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.J Pharmacol Exp Ther. 1992 May;261(2):638-42. J Pharmacol Exp Ther. 1992. PMID: 1349644
-
Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.J Pharmacol Exp Ther. 1977 Mar;200(3):598-605. J Pharmacol Exp Ther. 1977. PMID: 15099